Vertebral bone marrow fat fraction changes in postmenopausal women with breast cancer receiving combined aromatase inhibitor and bisphosphonate therapy

被引：0
|
作者：
Michael Dieckmeyer
Stefan Ruschke
Alexander Rohrmeier
Jan Syväri
Ingo Einspieler
Vanadin Seifert-Klauss
Monika Schmidmayr
Stephan Metz
Jan S. Kirschke
Ernst J. Rummeny
Claus Zimmer
Dimitrios C. Karampinos
Thomas Baum
机构：
[1] Technische Universität München,Department of Diagnostic and Interventional Neuroadiology, Klinikum rechts der Isar
[2] Technische Universität München,Department of Radiology, Klinikum rechts der Isar
[3] University Medical Center Regensburg,Department of Radiology
[4] Technische Universität München,Department of Gynecology and Obstetrics, Klinikum rechts der Isar
来源：
BMC Musculoskeletal Disorders | / 20卷
关键词：
Osteoporosis; Bisphosphonates; Aromatase inhibitor; Vertebral bone marrow; Proton density fat fraction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Vertebral bone marrow fat fraction changes in postmenopausal women with breast cancer receiving combined aromatase inhibitor and bisphosphonate therapy
    Dieckmeyer, Michael
    Ruschke, Stefan
    Rohrmeier, Alexander
    Syvaeri, Jan
    Einspieler, Ingo
    Seifert-Klauss, Vanadin
    Schmidmayr, Monika
    Metz, Stephan
    Kirschke, Jan S.
    Rummeny, Ernst J.
    Zimmer, Claus
    Karampinos, Dimitrios C.
    Baum, Thomas
    BMC MUSCULOSKELETAL DISORDERS, 2019, 20 (01)
  • [2] Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy
    Marilyn L. Kwan
    Song Yao
    Cecile A. Laurent
    Janise M. Roh
    Charles P. Quesenberry
    Lawrence H. Kushi
    Joan C. Lo
    Breast Cancer Research and Treatment, 2018, 168 : 523 - 530
  • [3] Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy
    Kwan, Marilyn L.
    Yao, Song
    Laurent, Cecile A.
    Roh, Janise M.
    Quesenberry, Charles P., Jr.
    Kushi, Lawrence H.
    Lo, Joan C.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (02) : 523 - 530
  • [4] Changes in Vertebral Marrow Fat Fraction Using 3D Fat Analysis & Calculation Technique Imaging Sequence in Aromatase Inhibitor-Treated Breast Cancer Women
    Wan, Taihu
    Zhu, Yuhang
    Han, Qinghe
    Liu, Lin
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [5] Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy
    Pedersini, Rebecca
    Amoroso, Vito
    Maffezzoni, Filippo
    Gallo, Fabio
    Turla, Antonella
    Monteverdi, Sara
    Ardine, Mara
    Ravanelli, Marco
    Vassalli, Lucia
    Rodella, Filippo
    Formenti, Anna Maria
    Volta, Alberto Dalla
    Simoncini, Edda Lucia
    Giustina, Andrea
    Maroldi, Roberto
    Berruti, Alfredo
    JAMA NETWORK OPEN, 2019, 2 (09)
  • [6] Bone Health in Postmenopausal Women with Breast Cancer Receiving Aromatase Inhibitors
    Zikan, Vit
    Zimovjanova, Martina
    Petruzelka, Lubos
    Pribylova, Jana
    Cabinakova, Michaela
    Raskova, Maria
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [7] Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition
    Van Poznak, Catherine
    BREAST CANCER RESEARCH, 2010, 12 (03):
  • [8] High prevalence of vertebral fractures in women with breast cancer starting aromatase inhibitor therapy
    Bouvard, B.
    Hoppe, E.
    Soulie, P.
    Georgin-Mege, M.
    Jadaud, E.
    Abadie-Lacourtoisie, S.
    Le Manac'h, A. Petit
    Laffitte, A.
    Levasseur, R.
    Audran, M.
    Chappard, D.
    Legrand, E.
    ANNALS OF ONCOLOGY, 2012, 23 (05) : 1151 - 1155
  • [9] Bone health in a prospective cohort of postmenopausal women receiving aromatase inhibitors for early breast cancer
    Servitja, Sonia
    Nogues, Xavier
    Prieto-Alhambra, Daniel
    Martinez-Garcia, Maria
    Garrigos, Laia
    Jesus Pena, Maria
    de Ramon, Marta
    Diez-Perez, Adolfo
    Albanell, Joan
    Tusquets, Ignasi
    BREAST, 2012, 21 (01) : 95 - 101
  • [10] Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole
    Brufsky, Adam
    Bundred, Nigel
    Coleman, Robert
    Lambert-Falls, Rosemary
    Mena, Raul
    Hadji, Peyman
    Jin, Lixian
    Schenk, Nora
    Ericson, Solveig
    Perez, Edith A.
    ONCOLOGIST, 2008, 13 (05) : 503 - 514
12345